Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Reteplase (BM 06.022) is a recombinant plasminogen activator consisting of the kringle 2 and protease domains of human tissue-type fibrinogen activator. Reteplase is produced by DNA technology in E. coli as a t-PA mutant, unglycosylated.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | Inquiry | |
50 mg | 6-8 weeks | Inquiry | |
100 mg | 6-8 weeks | Inquiry |
Description | Reteplase (BM 06.022) is a recombinant plasminogen activator consisting of the kringle 2 and protease domains of human tissue-type fibrinogen activator. Reteplase is produced by DNA technology in E. coli as a t-PA mutant, unglycosylated. |
Molecular Weight | N/A |
CAS No. | 133652-38-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Reteplase 133652-38-7 inhibitor inhibit